THSD7A Exacerbates Atherosclerosis via Activation of Signaling Axis αvβ3/CEBPD/IL1A
Advanced Science · 2026-11 · 13 (63)
DOI: 10.1002/advs.77422 ↗At a glance
Journal article in Advanced Science, published online on 2026-08-24. Written by Jiankun Liu and 15 co-authors. Institution: Aging and Vascular Diseases, Human Aging Research Institute and School of Life Science, Nanchang University, Jiangxi Key Laboratory of Aging and Dise…. Major MEDLINE topics: Atherosclerosis, Integrin alphaVbeta3, Interleukin-1alpha. 63 references. The full text is freely available (open access, CC BY 4.0). Funded by: Key Program of the National Natural Science Foundation of China, Jiangxi Province Key Laboratory of Aging and Disease.
Abstract (original language)
Our previous genome‐wide screening has linked THSD7A (thrombospondin type 1 domain containing 7A) gene to human coronary artery disease (CAD). How THSD7A contributes to atherosclerosis, however, remains unclear. In this study, we show THSD7A is increased in human carotid arteries and mouse atherosclerotic plaques. In apolipoprotein E knockout ( ApoE −/− ) mice, the overexpression of THSD7A increases monocyte‐endothelial adhesion and macrophage infiltration, exacerbating atherosclerotic lesions, whereas Thsd7A knockout ( Thsd7A −/− ) attenuates these phenotypic changes. Integrated single‐cell and bulk transcriptomic profiles demonstrate that THSD7A activates IL1A (Interleukin 1 alpha) signaling, augmenting endothelial inflammation. Mechanistically, THSD7A binds to integrin αvβ3, and such binding activates ERK (Extracellular signal‐regulated kinase) and augments IL1A ‐associated proinflammatory signaling. Notably, IL1A serves as a transcriptional target of CEBPD (CCAAT/enhancer‐binding protein delta), and CEBPD knockdown rescues THSD7A‐ mediated endothelial inflammation. These findings establish THSD7A as a novel and critical mediator in the regulation of the αvβ3/CEBPD/IL1A axis that controls endothelial inflammatory responses associated with atherosclerosis and demonstrate the importance of CEBPD as a downstream molecule in mediating THSD7A ‐associated signaling. This study positions THSD7A as both a genetic marker and a potential therapeutic target.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Aging and Vascular Diseases, Human Aging Research Institute and School of Life Science, Nanchang University, Jiangxi Key Laboratory of Aging and Diseases, Nanchang, China.
- Vascular Function Laboratory, Human Aging Research Institute and School of Life Science, Nanchang University, Jiangxi Key Laboratory of Human Aging, Nanchang, China.
ORCID profiles: Jiankun Liu, Hongfei Liu, Xueting Gong, Ya Zhao, Weixin Lv, Xueer Li, Xiao-Li Tian
Funding
- Key Program of the National Natural Science Foundation of China
- Jiangxi Province Key Laboratory of Aging and Disease
Cite
APA
Liu, J., Liu, H., Wan, Y., Wu, A., Qiu, J., Gong, X., Zhao, Y., Li, Y., Zhou, B., Zheng, Y., Wu, F., Zhu, Y., Lv, W., Li, X., Yuan, Q., & Tian, X. L. (2026). THSD7A Exacerbates Atherosclerosis via Activation of Signaling Axis αvβ3/CEBPD/IL1A. Advanced Science, 13(63). https://doi.org/10.1002/advs.77422
Vancouver
Liu J, Liu H, Wan Y, Wu A, Qiu J, Gong X, et al. THSD7A Exacerbates Atherosclerosis via Activation of Signaling Axis αvβ3/CEBPD/IL1A. Advanced Science. 2026;13(63). doi:10.1002/advs.77422
BibTeX
@article{Liu2026,
author = {Liu, Jiankun and Liu, Hongfei and Wan, Yiqi and Wu, Andong and Qiu, Jiayu and Gong, Xueting and Zhao, Ya and Li, Yuanyuan and Zhou, Bingbing and Zheng, Yangyi and Wu, Fang and Zhu, Yuanzheng and Lv, Weixin and Li, Xueer and Yuan, Qiang and Tian, Xiao-Li},
title = {THSD7A Exacerbates Atherosclerosis via Activation of Signaling Axis αvβ3/CEBPD/IL1A},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {63},
doi = {10.1002/advs.77422}
}
EUVIMED